Blue Jet Healthcare Limited
Healthcare›Healthcare›Pharmaceuticals & Biotechnology›Pharmaceuticals
Key metrics
Price as of 2026-07-17
Sign in for full ratios and TTM. Learn about these metrics →
Share price
NSE closing price from historical market data.
Loading price history…
Statement tables · Consolidated
Switches quarterly, P&L, balance sheet, and cash flow. Key metrics and ratios stay on consolidated when available.
Amounts in ₹ Cr · NSE preferred when both exchanges report the same period · tap + to expand rows
Quarterly results
Quarterly · ₹ Cr · tap + rows to expand
| Metric | Mar 2025 | Jun 2025 | Sept 2025 |
|---|---|---|---|
| Sales | 340 Cr | 355 Cr | 165 Cr |
| Operating expenses (approx.) | 188 Cr | 226 Cr | 86 Cr |
| EBITDA | 152 Cr | 129 Cr | 79 Cr |
| OPM % | 44.7% | 36.4% | 47.9% |
| Other income | 12 Cr | 8 Cr | 24 Cr |
| Interest | 0.03 Cr | 0.69 Cr | 5 Cr |
| Depreciation | 5 Cr | 6 Cr | 6 Cr |
| Profit before tax | 147 Cr | 123 Cr | 69 Cr |
| Tax % | 25.2% | 25.8% | 24.1% |
| Net profit | 110 Cr | 91 Cr | 52 Cr |
| EPS (₹) | ₹6.35 | ₹5.26 | ₹3.01 |
Profit & loss (annual)
Annual · last column is TTM · ₹ Cr · tap + to expand
| Metric | Mar 2025 | TTM |
|---|---|---|
| Sales | 1,030 Cr | Sign in for TTM |
| Operating expenses (approx.) | 606 Cr | Sign in for TTM |
| EBITDA | 424 Cr | Sign in for TTM |
| OPM % | 41.2% | Sign in for TTM |
| Other income | 46 Cr | Sign in for TTM |
| Interest | 0.10 Cr | Sign in for TTM |
| Depreciation | 18 Cr | Sign in for TTM |
| Profit before tax | 406 Cr | Sign in for TTM |
| Tax % | 24.8% | Sign in for TTM |
| Net profit | 305 Cr | Sign in for TTM |
| EPS (₹) | ₹17.59 | Sign in for TTM |
| Dividend payout % | 5.7% | Sign in for TTM |
Trailing twelve months totals and margin rows
Balance sheet
Annual · ₹ Cr · tap + rows to expand
| Metric | Mar 2025 |
|---|---|
| Equity capital | 35 Cr |
| Reserves | 1,098 Cr |
| Borrowings | — |
| Other liabilities | 284 Cr |
| Total liabilities | 1,418 Cr |
| Fixed assets (net) | 260 Cr |
| CWIP | 89 Cr |
| Investments | 187 Cr |
| Other assets | 1,006 Cr |
| Total assets | 1,418 Cr |
Cash flows
Annual · ₹ Cr · tap + rows to expand · last column includes FCF
| Metric | Mar 2025 |
|---|---|
| Cash from operating activity | 46 Cr |
| Cash from investing | -35 Cr |
| Cash from financing | -19 Cr |
| Net cash flow | -8 Cr |
| Free cash flow (OCF − Capex) | -34 Cr |
Ratios
Ratios as reported or derived per annual period.
| Metric | Mar 2025 |
|---|---|
| ROCE % | 35.8% |
| ROE % | 26.9% |
| Debtor days | — |
| Inventory days | 178 |
| Days payable | — |
| Cash conversion cycle | 178 |
| Debt / equity | — |
| Current ratio | 3.93 |
| Net debt / EBITDA | -0.08 |
Compare with peers
Loading peers…